Compile Data Set for Download or QSAR
Report error Found 251 for UniProtKB: P51787
LigandPNGBDBM50099566(2-(4-Fluoro-phenyl)-2-(2-fluoro-phenyl)-2-phenyl-a...)
Affinity DataIC50: 9nMAssay Description:Selectivity for gardos channel; (Gardos channel vs 2000 nM for the cardiac IKs channel).)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/25/2012
Entry Details Article
PubMed
LigandPNGBDBM710452(1-(3-methyl-1- bicyclo[1.1.1]pentanyl)-3- [(1S)-1-...)
Affinity DataEC50:  20nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710476(1-(3-fluoro-1- bicyclo[1.1.1]pentanyl)-3- [[3- (tr...)
Affinity DataEC50:  30nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710453(1-(3-propan-2-yl-1- bicyclo[1.1.1]pentanyl)-3- [(1...)
Affinity DataEC50:  40nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710461(1-[dideuterio-[3- (trifluoromethoxy)phenyl] methyl...)
Affinity DataEC50:  40nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710461(1-[dideuterio-[3- (trifluoromethoxy)phenyl] methyl...)
Affinity DataEC50:  40nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710460(1-[[3- (fluoromethoxy)phenyl] methyl]-3-[3-(triflu...)
Affinity DataEC50:  50nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily E/KQT member 1(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50106236((3R,4S)-Ethanesulfonic acid (6-benzyloxy-3-hydroxy...)
Affinity DataIC50: 50nMAssay Description:Inhibition of human IKs-channel expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM710438(1-[(1R)-1-(3-bromophenyl)- 2-hydroxyethyl]-3-[3- (...)
Affinity DataEC50:  50nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710436(1-(3-fluoro-1- bicyclo[1.1.1]pentanyl)-3- [(1S)-1-...)
Affinity DataEC50:  60nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710484(1-[[3-(2,2,2- trifluoroethoxy)phenyl] methyl]-3-[3...)
Affinity DataEC50:  60nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710463(1-(1- bicyclo[1.1.1]pentanyl)-3- [1-[3- (trifluoro...)
Affinity DataEC50:  60nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710474(1-[(1R)-2-hydroxy-1-[3- (trifluoromethyl)phenyl] e...)
Affinity DataEC50:  60nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710435(1-(3-fluoro-1- bicyclo[1.1.1]pentanyl)-3- [(1S)-1-...)
Affinity DataEC50:  70nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710451(1-(1- bicyclo[1.1.1]pentanyl)-3- [(1S)-1-[3- (trif...)
Affinity DataEC50:  70nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710433(1-[3-(trifluoromethyl)-1- bicyclo[1.1.1]pentanyl]-...)
Affinity DataEC50:  70nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710462(1-[(3-bromophenyl)methyl]- 3-[3-(trifluoromethyl)-...)
Affinity DataEC50:  70nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710481(1-[(1R)-2-hydroxy-1-[3- (trifluoromethoxy)phenyl] ...)
Affinity DataEC50:  80nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710446(1-(3-methyl-1- bicyclo[1.1.1]pentanyl)-3- [[3- (tr...)
Affinity DataEC50:  80nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710428(1-[[3- (trifluoromethoxy)phenyl] methyl]-3-[3- (tr...)
Affinity DataEC50:  80nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710455(1-[[3- (difluoromethoxy)phenyl] methyl]-3-[3- (tri...)
Affinity DataEC50:  80nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710455(1-[[3- (difluoromethoxy)phenyl] methyl]-3-[3- (tri...)
Affinity DataEC50:  80nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710442(1-[(1S)-1-(3- bromophenyl)ethyl]-3-(3- fluoro-1- b...)
Affinity DataEC50:  90nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710483(1-[[2-fluoro-3- (trifluoromethoxy)phenyl] methyl]-...)
Affinity DataEC50:  100nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710458(1-[(3- ethynylphenyl)methyl]-3-[3- (trifluoromethy...)
Affinity DataEC50:  100nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710472(1-(3-methyl-1- bicyclo[1.1.1]pentanyl)-3- [[3- (tr...)
Affinity DataEC50:  100nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710447(1-(3-propan-2-yl-1- bicyclo[1.1.1]pentanyl)-3- [[3...)
Affinity DataEC50:  120nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily E/KQT member 1(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50099582(N-[(3R,4S)-3-Hydroxy-2,2-dimethyl-6-(4,4,4-trifluo...)
Affinity DataIC50: 120nMAssay Description:Inhibition of human IKs-channel expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily E/KQT member 1(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50099582(N-[(3R,4S)-3-Hydroxy-2,2-dimethyl-6-(4,4,4-trifluo...)
Affinity DataIC50: 120nMAssay Description:Inhibition of IKs currents in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/25/2012
Entry Details Article
PubMed
LigandPNGBDBM710448(1-[3-(difluoromethyl)-1- bicyclo[1.1.1]pentanyl]-3...)
Affinity DataEC50:  160nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710464(1-[1-[3- (difluoromethoxy)phenyl] ethyl]-3-(3-fluo...)
Affinity DataEC50:  180nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily E/KQT member 1(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50106233(N-(6-Benzyloxy-3-hydroxy-2,2-dimethyl-chroman-4-yl...)
Affinity DataIC50: 200nMAssay Description:Inhibition of human IKs-channel expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM710473(1-[(3-cyano-2- fluorophenyl)methyl]-3-[3- (trifluo...)
Affinity DataEC50:  210nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710477(1-(1- bicyclo[1.1.1]pentanyl)-3- [(1S)-1-[3- (trif...)
Affinity DataEC50:  230nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710437(1-(3-fluoro-1- bicyclo[1.1.1]pentanyl)-3- [[3- (tr...)
Affinity DataEC50:  240nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710478(1-[(3-cyanophenyl)- dideuteriomethyl]-3-[3- (trifl...)
Affinity DataEC50:  240nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710478(1-[(3-cyanophenyl)- dideuteriomethyl]-3-[3- (trifl...)
Affinity DataEC50:  240nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily E/KQT member 1(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50106231(N-[3-Hydroxy-2,2-dimethyl-6-(4,4,4-trifluoro-butox...)
Affinity DataIC50: 240nMAssay Description:Inhibition of human IKs-channel expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM710431(1-[(3-cyanophenyl)methyl]- 3-[3-(trifluoromethyl)-...)
Affinity DataEC50:  250nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710431(1-[(3-cyanophenyl)methyl]- 3-[3-(trifluoromethyl)-...)
Affinity DataEC50:  250nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily E/KQT member 1(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50106232(N-(6-Butoxy-3-hydroxy-2,2-dimethyl-chroman-4-yl)-N...)
Affinity DataIC50: 250nMAssay Description:Inhibition of human IKs-channel expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50390916(CHEMBL2070953)
Affinity DataEC50:  260nMAssay Description:Activation of Kv7.1 channel expressed in CHO cells assessed as depolarization-induced thallium influx after 3 mins by patch clamp assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMedPDB3D3D Structure (crystal)
LigandPNGBDBM710456(1-[[3-(oxetan-3- yl)phenyl]methyl]-3-[3- (trifluor...)
Affinity DataEC50:  280nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710429(1-[(1R)-1-(3-chlorophenyl)- 2-hydroxyethyl]-3-[3- ...)
Affinity DataEC50:  300nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710429(1-[(1R)-1-(3-chlorophenyl)- 2-hydroxyethyl]-3-[3- ...)
Affinity DataEC50:  300nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710480(1-(1- bicyclo[1.1.1]pentanyl)-3- [(1R)-2-hydroxy-1...)
Affinity DataEC50:  310nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM710444(1-[(1S)-1-(3- chlorophenyl)ethyl]-3-(3- fluoro-1- ...)
Affinity DataEC50:  360nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily E/KQT member 1(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50106237((3S,4R)-Ethanesulfonic acid (6-benzyloxy-3-hydroxy...)
Affinity DataIC50: 400nMAssay Description:Inhibition of human IKs-channel expressed in Xenopus oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM710457(1-[[3- (difluoromethyl)phenyl] methyl]-3-[3-(trifl...)
Affinity DataEC50:  400nMAssay Description:Solutions were of the following composition:Earle's balanced salt solution (in mM): 135 NaCl, 5.4 KCl, 5 Glucose, 2 CaCl2), 1 MgCl2, 5 HEPES, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
US Patent

LigandPNGBDBM50390878(CHEMBL2070970)
Affinity DataEC50:  420nMAssay Description:Activation of Kv7.1 channel expressed in CHO cells assessed as depolarization-induced thallium influx after 3 mins by patch clamp assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
Displayed 1 to 50 (of 251 total ) | Next | Last >>
Jump to: